Terms: = Colorectal cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824 AND Treatment
6 results:
1. Hafnium (Hf)-Chelating Porphyrin-Decorated Gold Nanosensitizers for Enhanced Radio-Radiodynamic Therapy of Colon Carcinoma.
Li J; Lv Z; Guo Y; Fang J; Wang A; Feng Y; Zhang Y; Zhu J; Zhao Z; Cheng X; Shi H
ACS Nano; 2023 Dec; 17(24):25147-25156. PubMed ID: 38063344
[TBL] [Abstract] [Full Text] [Related]
2. Reactive Oxygen Species as Mediators of Disease Progression and Therapeutic Response in colorectal cancer.
Lyons NJ; Giri R; Begun J; Clark D; Proud D; He Y; Hooper JD; Kryza T
Antioxid Redox Signal; 2023 Jul; 39(1-3):186-205. PubMed ID: 36792932
[No Abstract] [Full Text] [Related]
3. Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review.
Duan H; Gao W; Wang L; Cao F; Teng L
Diagn Pathol; 2021 Apr; 16(1):30. PubMed ID: 33836796
[TBL] [Abstract] [Full Text] [Related]
4. NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis.
Van Treeck BJ; Thangaiah JJ; Torres-Mora J; Stevens TM; Rothermundt C; Fassan M; Loupakis F; Diebold J; Hornick JL; Halling KC; Folpe AL
Mod Pathol; 2021 Aug; 34(8):1547-1557. PubMed ID: 33714983
[TBL] [Abstract] [Full Text] [Related]
5. Performance of tumor growth kinetics as an imaging biomarker for response assessment in colorectal liver metastases: correlation with FDG PET.
Seyal AR; Parekh K; Arslanoglu A; Gonzalez-Guindalini FD; Tochetto SM; Velichko YS; Yaghmai V
Abdom Imaging; 2015 Oct; 40(8):3043-51. PubMed ID: 26353898
[TBL] [Abstract] [Full Text] [Related]
6. Pre-operative radiotherapy in rectal cancer: evaluation of irradiation effects on cellular undifferentiation and its influence on prognosis.
Reis Neto JA; Quilici FA; Cordeiro F; Ciquini S; Reis JA
Hepatogastroenterology; 1999; 46(29):2825-30. PubMed ID: 10576354
[TBL] [Abstract] [Full Text] [Related]
